The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 07, 2014

Filed:

Feb. 25, 2011
Applicants:

Armin Heckel, Biberach, DE;

Frank Himmelsbach, Mittelbiberach, DE;

Joerg Kley, Mittelbiberach, DE;

Thorsten Lehmann-lintz, Ochsenhausen, DE;

Norbert Redemann, Biberach, DE;

Achim Sauer, Ravensburg-Torkenweiler, DE;

Leo Thomas, Biberach, DE;

Dieter Wiedenmayer, Biberach, DE;

Phillip Black, Saffron Walden Essex, GB;

Wesley Blackaby, Saffron Walden Essex, GB;

Ian Linney, Saffron Walden Essex, GB;

Matthias Austen, Goettingen, DE;

John Danilewicz, Canterbury, GB;

Martin Schneider, Goettingen, DE;

Kay Schreiter, Goettingen, DE;

Inventors:

Armin Heckel, Biberach, DE;

Frank Himmelsbach, Mittelbiberach, DE;

Joerg Kley, Mittelbiberach, DE;

Thorsten Lehmann-Lintz, Ochsenhausen, DE;

Norbert Redemann, Biberach, DE;

Achim Sauer, Ravensburg-Torkenweiler, DE;

Leo Thomas, Biberach, DE;

Dieter Wiedenmayer, Biberach, DE;

Phillip Black, Saffron Walden Essex, GB;

Wesley Blackaby, Saffron Walden Essex, GB;

Ian Linney, Saffron Walden Essex, GB;

Matthias Austen, Goettingen, DE;

John Danilewicz, Canterbury, GB;

Martin Schneider, Goettingen, DE;

Kay Schreiter, Goettingen, DE;

Assignee:

Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 495/04 (2006.01); A61K 31/519 (2006.01); A61K 31/5377 (2006.01); A61K 31/56 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); A61P 25/28 (2006.01); A61P 13/12 (2006.01); A61K 31/395 (2006.01);
U.S. Cl.
CPC ...
C07D 495/04 (2013.01);
Abstract

The present invention relates to novel thienopyrimidine compounds of general formula pharmaceutical compositions comprising these compounds and their therapeutic use for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.


Find Patent Forward Citations

Loading…